Unknown

Dataset Information

0

The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells.


ABSTRACT: While signals that activate group 3 innate lymphoid cells (ILC3s) have been described, the factors that negatively regulate these cells are less well understood. Here we found that the tumor necrosis factor (TNF) superfamily member receptor activator of nuclear factor ?B ligand (RANKL) suppressed ILC3 activity in the intestine. Deletion of RANKL in ILC3s and T cells increased C-C motif chemokine receptor 6 (CCR6)+ ILC3 abundance and enhanced production of interleukin-17A (IL-17A) and IL-22 in response to IL-23 and during infection with the enteric murine pathogen Citrobacter rodentium. Additionally, CCR6+ ILC3s produced higher amounts of the master transcriptional regulator ROR?t at steady state in the absence of RANKL. RANKL-mediated suppression was independent of T cells, and instead occurred via interactions between CCR6+ ILC3s that expressed both RANKL and its receptor, RANK. Thus, RANK-RANKL interactions between ILC3s regulate ILC3 abundance and activation, suggesting that cell clustering may control ILC3 activity.

SUBMITTER: Bando JK 

PROVIDER: S-EPMC6086389 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells.

Bando Jennifer K JK   Gilfillan Susan S   Song Christina C   McDonald Keely G KG   Huang Stanley C-C SC   Newberry Rodney D RD   Kobayashi Yasuhiro Y   Allan David S J DSJ   Carlyle James R JR   Cella Marina M   Colonna Marco M  

Immunity 20180529 6


While signals that activate group 3 innate lymphoid cells (ILC3s) have been described, the factors that negatively regulate these cells are less well understood. Here we found that the tumor necrosis factor (TNF) superfamily member receptor activator of nuclear factor κB ligand (RANKL) suppressed ILC3 activity in the intestine. Deletion of RANKL in ILC3s and T cells increased C-C motif chemokine receptor 6 (CCR6)<sup>+</sup> ILC3 abundance and enhanced production of interleukin-17A (IL-17A) and  ...[more]

Similar Datasets

| S-EPMC3603457 | biostudies-literature
| S-EPMC3998636 | biostudies-literature
| S-EPMC5505788 | biostudies-literature
| S-EPMC7611333 | biostudies-literature
| S-EPMC7010567 | biostudies-literature
| S-EPMC4913864 | biostudies-literature
| S-EPMC4165592 | biostudies-literature
| S-EPMC5479798 | biostudies-literature
| S-EPMC4925019 | biostudies-literature
| S-EPMC10503660 | biostudies-literature